【结 构 式】 |
【药物名称】Cisplatin, DDP-H, NSC-119875, CPDC, CACP, CDDP, Cis-DDP, Platinex, Briplatin, Randa, Platinol-AQ, Platinol, Neoplatin 【化学名称】cis-Diaminedichloroplatinum(II) 【CA登记号】15663-27-1 【 分 子 式 】H6Cl2N2Pt 【 分 子 量 】300.05722 |
【开发单位】Bristol-Myers Squibb (Originator), Ferring (Licensee), Nippon Kayaku (Codevelopment) 【药理作用】Bladder Cancer Therapy , Liver Cancer Therapy, Oncolytic Drugs, Ovarian Cancer Therapy, Solid Tumors Therapy, BIRC4 Expression Enhancers, DNA Alkylating Drugs, Platinum Complexes, TNFSF6 Expression Inhibitors |
合成路线1
The reduction of potassium hexachloroplatinate (I) with hydrazine dihydrochloride (II) in hot water gives potassium tetrachloroplatinate (III), which is finally treated with NH4Cl or NH4OAc and aqueous ammonia.
【1】 Lebendinskii, V.V.; Golovnya, V.A.; Ammonia compounds of bivalent platinum. Izvest Sektora Platiny i Drug Blagorod Metal Inst Obshchei i Neorg Khim Akad Nauk S.S.S.R 1947, 20, 95-98. |
【2】 Cowan, D.O.; Kauffman, G.B.; cis- and trans-Dichlorodiammineplatinum (II). Inorg Synth 1963, 7, 239-245. |
【3】 Castaner, J.; Woodman, R.J.; Cisplatin. Drugs Fut 1978, 3, 8, 574. |